A Wisconsin based biotechnology company claims that one of their clinical studies has shown that a protein extracted from a unique species of bioluminescent jellyfish helps improve the memories of Alzheimers patients.
Using a randomized controlled trial, Quincy Bioscience reports interim results indicating that participants who took an experimental drug with the jellyfish protein tested 14% higher on cognitive tests than those who received a placebo.
Continue reading on Greenopolis (link)
Levi Novey 